The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Sv Life Sciences Fund Iv Strategic Partners, L. P. since 2014.
The trader's CIK number is 1392309.
At the time of the last reporting, Sv Life Sciences Fund Iv Strategic Partners, L. P. was the 10% Owner of Ocular Therapeutix, Inc. (stock ticker symbol OCUL).
Also see all insider trading activities at Ocular Therapeutix, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | OPHT | 0 | $0 | 8,186,364 | $312,205,324 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | OCUL | 0 | $0 | 1,119,000 | $24,618,000 | 0 | $0 |
2. Ocular Therapeutix, Inc (OCUL)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-06-04 | OPHT | Sale | 1,966,935 | 42.54 | 83,673,414 |
| 2014-06-02 | OPHT | Sale | 341,850 | 39.91 | 13,643,233 |
| 2014-06-03 | OPHT | Sale | 1,523,769 | 40.81 | 62,185,012 |
| 2014-05-29 | OPHT | Sale | 716,361 | 40.99 | 29,363,637 |
| 2014-05-30 | OPHT | Sale | 215,508 | 41.01 | 8,837,983 |
| 2014-05-27 | OPHT | Sale | 293,211 | 39.87 | 11,690,322 |
| 2014-05-28 | OPHT | Sale | 686,916 | 40.33 | 27,703,322 |
| 2014-05-22 | OPHT | Sale | 102,000 | 37.57 | 3,832,140 |
| 2014-05-23 | OPHT | Sale | 228,450 | 38.34 | 8,758,773 |
| 2014-02-18 | OPHT | Sale | 2,111,364 | 29.61 | 62,517,488 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-06-10 | OCUL | Sale | 1,119,000 | 22.00 | 24,618,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sv Life Sciences Fund Iv Strategic Partners, L. P. (10% Owner of Ocular Therapeutix, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.